Boosting Cytotoxic Antibodies against Cancer
- PMID: 32142673
- DOI: 10.1016/j.cell.2020.02.025
Boosting Cytotoxic Antibodies against Cancer
Abstract
Monoclonal antibodies (mAbs) targeting antigens expressed at the surface of tumor cells are widely used for cancer control in clinics, but these treatments need to be improved. Chew et al. show how an old drug, prochlorperazine, could be repurposed to enhance the efficacy of anti-tumor mAbs by increasing the cell-surface expression of tumor antigens.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests L.G. and E.V. are employees of Innate Pharma.
Comment on
-
Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies.Cell. 2020 Mar 5;180(5):895-914.e27. doi: 10.1016/j.cell.2020.02.019. Cell. 2020. PMID: 32142680
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical